advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (25)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation49184 Comparison of the Long-Term Effects of Various Topical Antiglaucoma Medications on Meibomian Glands
Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S
Cornea 2012; 31: 1229-1234
49353 A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma
Garcia-Feijoo J; Sampaolesi JR
Clinical Ophthalmology 2012; 6: 441-446
49154 Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication
O',Hare F; Ghosh S; Lamoureux E; Vajpayee RB; Crowston JG
Clinical and Experimental Ophthalmology 2012; 40: 675-681
48452 Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost
Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
Journal of Glaucoma 2012; 21: 60-64
49003 Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension
Chabi A; Varma R; Tsai JC; Lupinacci R; Pigeon J; Baranak C; Noble L; Lines C; Ho TW
American Journal of Ophthalmology 2012; 153: 1187-1196
48963 Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
Janulevi?ien? I; Derka? I; Grybauskiene L; Paulauskait? R; Gromnickaite R; Kuzmien? L
Clinical Ophthalmology 2012; 6: 103-109
48735 Comparison of human ocular distribution of bimatoprost and latanoprost
Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 134-145
48966 Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
Natarajan JV; Ang M; Darwitan A; Chattopadhyay S; Wong TT; Venkatraman SS
International Journal of Nanomedicine 2012; 7: 123-131
49097 Overview of the BAK-free travoprost /timolol BAK-free fixed combination
Konstas AG; Quaranta L; Realini T
Expert Opinion in Pharmacotherapy 2012; 13: 757-766
48854 Thermoreversible gel for delivery of activin receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery
Sutariya V; Miladore N; Geldenhuys W; Bhatia D; Wehrung D; Nakamura H
Pharmaceutical Development and Technology 2013; 18: 957-962
48672 Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea
Lopilly Park HY; Kim JH; Lee KM; Park CK
Experimental Eye Research 2012; 94: 13-21
48602 Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation
Aburahma MH; Mahmoud AA
AAPS PharmSciTech 2011; 12: 1335-1347
49051 Drug delivery by contact lens in spontaneously glaucomatous dogs
Peng CC; Ben-Shlomo A; MacKay EO; Plummer CE; Chauhan A
Current Eye Research 2012; 37: 204-211
48818 A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine
Lai JY; Hsieh AC
Biomaterials 2012; 33: 2372-2387
49144 Free radicals and the pH of topical glaucoma medications: a lifetime of ocular chemical injury?
Lockington D; Macdonald EC; Stewart P; Young D; Caslake M; Ramaesh K
Eye 2012; 26: 734-741
48791 Timogel® vs timolol 0.5% ophthalmic solution: efficacy, safety, and acceptance
Rolle T; Curto D; Alovisi C; Franzone M; Brogliatti B; Grignolo FM
European Journal of Ophthalmology 0; 22: 28-33
48823 Biodegradable Microfabricated Plug-Filters for Glaucoma Drainage Devices
Maleki T; Chitnis G; Park J; Cantor LB; Ziaie B
IEEE Transactions on Bio-Medical Engineering 2012; 59: 1507-1513
48653 A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometry
Kahook MY; Fechtner RD; Katz LJ; Noecker RJ; Ammar DA
Current Eye Research 2012; 37: 101-108
49318 Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb
Lallemand F; Daull P; Benita S; Buggage R; Garrigue JS
Journal of Drug Delivery 2012; 2012: 604204
49081 Effects of long-term topical anti-glaucoma medications on meibomian glands
Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S
Graefe's Archive for Clinical and Experimental Ophthalmology 2012; 250: 1181-1185
49016 New Mucoadhesive Chitosan Film for Ophthalmic Drug Delivery of Timolol Maleate: In Vivo Evaluation
Fulgê,ncio GD; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Jú,nior AD
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 350-358
49041 Generic versus brand-name North American topical glaucoma drops
Mammo ZN; Flanagan JG; James DF; Trope GE
Canadian Journal of Ophthalmology 2012; 47: 55-61
48948 Topical drug delivery to the eye: dorzolamide
Loftsson T; Jansook P; Stefá,nsson E
Acta Ophthalmologica 2012; 90: 603-608
48921 First experience with BAK-free travoprost 0.004% in topical glaucoma medication
Gado AS; MacKy TA
Clinical Ophthalmology 2012; 6: 1-4
49331 Ocular surface and external filtration surgery: mutual relationships
Baudouin C
Developments in Ophthalmology 2012; 50: 64-78
